Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
基本信息
- 批准号:7447508
- 负责人:
- 金额:$ 3.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-03 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acinar CellAcinus organ componentAdenovirusesAffectAmericanAntisense OligonucleotidesAutoimmune DiseasesAutoimmune ProcessBindingCapsidCapsid ProteinsCellsCoxsackie VirusesCytosolDNADataDependenceDevelopmentDiagnosisDiseaseDisease ProgressionDistantDrug Delivery SystemsEndocytosisEtiologyEye diseasesFiberFunctional disorderFutureGoalsHeparinHeparitin SulfateHistocompatibility Antigens Class IIntracellular MembranesKnowledgeLacrimal gland structureLeadLiquid substanceMediatingMembraneMolecularMorbidity - disease rateOligonucleotidesOryctolagus cuniculusParticipantPathway interactionsPeptide antibodiesPeptidesPharmaceutical PreparationsProteinsRecombinantsRelative (related person)ResearchSerotypingSiteSjogren&aposs SyndromeSmall Interfering RNASurfaceSymptomsSystemTestingTherapeuticViralVirusWomanWorkadenovirus penton proteinadenovirus receptorbaseeye drynessglycosaminoglycan receptorinsightlacrimallacrimal acininext generationnovelocular surfacepolysulfated glycosaminoglycanprospectivereceptorreceptor bindingreceptor functionremediationresearch studytherapeutic targettraffickinguptake
项目摘要
A major contribution to ocular morbidity is lacrimal dysfunction, affecting over 10 million Americans. The
principal cell of the lacrimal gland and primary contributor of proteins into ocular surface fluid is the lacrimal
acinar cell, which is the target of much of the ocular research into the etiology of dry eye diseases including
the severe autoimmune disease, Sjogren's syndrome. Ongoing studies are now shedding insights into the
precise mechanisms involved in initiation, development and progression of disease, suggesting that
dentification of prospective therapeutic targets is likely in the not so distant future. However, we are still very
limited in our ability to specifically target the next generation of macromolecular drugs, particularly DNA-,
protein- or peptide based drugs, to the lacrimal gland, raising the possibility that we may soon identify
advanced therapies for treatment of severe dry eye diseases but will be unable to deliver these drugs to the
target site. Our focus here is to explore the unusual and possibly unique uptake mechanism utilized for
lacrimal acinar internalization of adenovirus serotype 5 (Ad5). We have demonstrated in lacrimal acinar cells
that Ad5 utilizes a unique fiber-dependent internalization pathway, in contrast to the penton-dependent
internalization described in other systems. We hypothesize that Ad5 may use multiple fiber receptors for
binding and entry in lacrimal acini, and further that one or more of these entry pathways is either unusually
robust or unique to lacrimal acini, explaining the unusual fiber-dependence of entry in tandem with the high
efficiency of viral transduction in lacrimal acini. We propose to characterize the participants in this novel
fiber-dependent internalization pathway at the molecular level, with a particular focus on coxsackievirus
adenovirus receptor, major histocompatibility complex class 1 and heparin sulfate-glycosaminoglycan
receptors, and their different modes of endocytosis. The aims are as follows:
Aim #1. Does coxsackievirus adenovirus receptor mediate fiber-dependent Ad5 internalization or free fiber
internalization in lacrimal acini?
Aim #2. What other receptors participate in fiber-dependent Ad5 internalization or free fiber internalization in
lacrimal acini?
Aim #3. What intracellular trafficking pathways mediate fiber-dependent Ad5 internalization or free fiber
internalization in lacrimal acini?
At the conclusion of this work, we will have elucidated the contributions of specific receptors and endocytic
internalization pathways responsible for fiber-dependent internalization of Ad5. We will have determined to
what extent the recombinant fiber or knob, the terminal region of the fiber protein, can recapitulate these
pathways. Finally, we will have tested proof-of-principle experiments to determine whether fiber or knob can
facilitate entry of antisense oligonucleotides and proteins into lacrimal acinar cytosol.
导致眼部发病的一个主要因素是泪道功能障碍,影响着超过 1000 万美国人。这
泪腺的主要细胞和眼表液体中蛋白质的主要贡献者是泪腺
腺泡细胞,它是许多干眼病病因学眼部研究的目标,包括
严重的自身免疫性疾病,干燥综合征。正在进行的研究正在揭示有关
涉及疾病发生、发展和进展的精确机制,表明
在不久的将来可能会确定预期的治疗靶点。然而,我们仍然很
我们专门针对下一代大分子药物(尤其是 DNA)的能力有限,
基于蛋白质或肽的药物,进入泪腺,提高了我们很快识别出的可能性
治疗严重干眼病的先进疗法,但无法将这些药物运送到
目标站点。我们这里的重点是探索用于的不寻常且可能独特的吸收机制
腺病毒血清型 5 (Ad5) 的泪腺腺泡内化。我们已经在泪腺腺泡细胞中证明
Ad5 利用独特的纤维依赖性内化途径,与五邻体依赖性相比
其他系统中描述的内化。我们假设 Ad5 可能使用多种纤维受体
泪腺腺泡中的结合和进入,并且进一步这些进入途径中的一个或多个是异常的
泪腺腺泡的强健或独特,解释了与高泪腺泡相伴的不寻常的纤维依赖性
泪腺腺泡病毒转导的效率。我们建议描绘这部小说中的参与者
分子水平上的纤维依赖性内化途径,特别关注柯萨奇病毒
腺病毒受体、主要组织相容性复合物 1 类和硫酸肝素-糖胺聚糖
受体及其不同的内吞作用模式。目标如下:
目标#1。柯萨奇病毒腺病毒受体介导纤维依赖性Ad5内化还是游离纤维
泪腺腺泡内化?
目标#2。还有哪些其他受体参与纤维依赖性 Ad5 内化或游离纤维内化
泪腺腺泡?
目标#3。哪些细胞内运输途径介导纤维依赖性 Ad5 内化或游离纤维
泪腺腺泡内化?
在这项工作结束时,我们将阐明特定受体和内吞作用的贡献
负责 Ad5 纤维依赖性内化的内化途径。我们将决心
重组纤维或旋钮(纤维蛋白的末端区域)可以在多大程度上重现这些
途径。最后,我们将测试原理验证实验,以确定光纤或旋钮是否可以
促进反义寡核苷酸和蛋白质进入泪腺腺泡细胞质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah F Hamm-Alvarez其他文献
Sarah F Hamm-Alvarez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah F Hamm-Alvarez', 18)}}的其他基金
Development of a novel tear-based biomarker assay for diagnosis of Parkinson's disease using RT-QuIC
使用 RT-QuIC 开发一种新型基于泪液的生物标志物检测方法来诊断帕金森病
- 批准号:
10227242 - 财政年份:2020
- 资助金额:
$ 3.65万 - 项目类别:
Development of a novel tear-based biomarker assay for diagnosis of Parkinson's disease using RT-QuIC
使用 RT-QuIC 开发一种新型基于泪液的生物标志物检测方法来诊断帕金森病
- 批准号:
10057848 - 财政年份:2020
- 资助金额:
$ 3.65万 - 项目类别:
Protein-polymer nanomedicine for Sjogren's Syndrome
用于治疗干燥综合症的蛋白质聚合物纳米药物
- 批准号:
10662981 - 财政年份:2017
- 资助金额:
$ 3.65万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7394357 - 财政年份:2006
- 资助金额:
$ 3.65万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7797328 - 财政年份:2006
- 资助金额:
$ 3.65万 - 项目类别:
Ad5 Fiber Entry and Trafficking in Lacrimal Acini
Ad5 纤维在泪腺泡中的进入和运输
- 批准号:
7075776 - 财政年份:2006
- 资助金额:
$ 3.65万 - 项目类别: